Suppr超能文献

基于两条修正的科赫法则探究炎症性肠病中的微生物群落失调及微生物治疗策略。

Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates.

作者信息

Zhao HanZheng, Zhang WenHui, Cheng Die, You LiuPing, Huang YueNan, Lu YanJie

机构信息

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.

出版信息

Front Med (Lausanne). 2022 Nov 10;9:1023896. doi: 10.3389/fmed.2022.1023896. eCollection 2022.

Abstract

Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn's disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been generally believed that the environment, immune disorders, genetic susceptibility, and intestinal microbes are the main factors for the disease pathogenesis. With the development of the sequencing technology, microbial factors have received more and more attention. The gut microbiota is in a state of precise balance with the host, in which the host immune system is tolerant to immunogenic antigens produced by gut commensal microbes. In IBD patients, changes in the balance between pathogenic microorganisms and commensal microbes lead to changes in the composition and diversity of gut microbes, and the balance between microorganisms and the host would be disrupted. This new state is defined as dysbiosis. It has been confirmed, in both clinical and experimental settings, that dysbiosis plays an important role in the occurrence and development of IBD, but the causal relationship between dysbiosis and inflammation has not been elucidated. On the other hand, as a classic research method for pathogen identification, the Koch's postulates sets the standard for verifying the role of pathogens in disease. With the further acknowledgment of the disease pathogenesis, it is realized that the traditional Koch's postulates is not applicable to the etiology research (determination) of infectious diseases. Thus, many researchers have carried out more comprehensive and complex elaboration of Koch's postulates to help people better understand and explain disease pathogenesis through the improved Koch's postulates. Therefore, focusing on the new perspective of the improved Koch's postulates is of great significance for deeply understanding the relationship between dysbiosis and IBD. This article has reviewed the studies on dysbiosis in IBD, the use of microbial agents in the treatment of IBD, and their relationship to the modified Koch's postulates.

摘要

炎症性肠病(IBD)是一种发生在肠道的慢性非特异性炎症性疾病。它主要分为两种亚型,即克罗恩病(CD)和溃疡性结肠炎(UC)。目前,其发病机制尚未完全阐明,但一般认为环境、免疫紊乱、遗传易感性和肠道微生物是该疾病发病的主要因素。随着测序技术的发展,微生物因素受到越来越多的关注。肠道微生物群与宿主处于精确平衡的状态,其中宿主免疫系统对肠道共生微生物产生的免疫原性抗原具有耐受性。在IBD患者中,致病微生物与共生微生物之间平衡的改变导致肠道微生物组成和多样性的变化,微生物与宿主之间的平衡将被打破。这种新状态被定义为生态失调。在临床和实验环境中均已证实,生态失调在IBD的发生和发展中起重要作用,但生态失调与炎症之间的因果关系尚未阐明。另一方面,作为病原体鉴定的经典研究方法,科赫法则为验证病原体在疾病中的作用设定了标准。随着对疾病发病机制的进一步认识,人们意识到传统的科赫法则不适用于传染病的病因学研究(确定)。因此,许多研究人员对科赫法则进行了更全面、更复杂的阐述,以帮助人们通过改进后的科赫法则更好地理解和解释疾病发病机制。因此,关注改进后的科赫法则的新视角对于深入理解生态失调与IBD之间的关系具有重要意义。本文综述了IBD中生态失调的研究、微生物制剂在IBD治疗中的应用及其与改良科赫法则的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7590/9684636/a42c06c9fd5c/fmed-09-1023896-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验